TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
Microalbumin test is a type of urine test that is used to diagnose kidney diseases. It is also used to evaluate the risk of kidney diseases among the patients diagnosed with diabetes or diabetic retinopathy.
This report contains market size and forecasts of Microalbumin Test in Global, including the following market information:
The global Microalbumin Test market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Analyzer Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Microalbumin Test include Roche, Abbott, Danaher, Siemens, Nova Biomedical, ARKRAY, OPTI Medical, ACON Laboratories and Sysmex, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Microalbumin Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Microalbumin Test Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Microalbumin Test Market Segment Percentages, by Type, 2021 (%)
Global Microalbumin Test Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Microalbumin Test Market Segment Percentages, by Application, 2021 (%)
Global Microalbumin Test Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Microalbumin Test Market Segment Percentages, By Region and Country, 2021 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include: